Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09JVJ
|
|||
| Drug Name |
Aminopyrimidine derivative 10
|
|||
| Synonyms |
PMID26293650-Compound-47
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Myrexis
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C29H34N6O4
|
|||
| Canonical SMILES |
CN(C)CCN(C)C(=O)C1=C(C=C(C=C1)NC2=NC=CC(=N2)C3=CC(=C(C=C3)OC4CCOCC4)C#N)OC
|
|||
| InChI |
1S/C29H34N6O4/c1-34(2)13-14-35(3)28(36)24-7-6-22(18-27(24)37-4)32-29-31-12-9-25(33-29)20-5-8-26(21(17-20)19-30)39-23-10-15-38-16-11-23/h5-9,12,17-18,23H,10-11,13-16H2,1-4H3,(H,31,32,33)
|
|||
| InChIKey |
XAXIBPFXBWPLTP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | NF-kappa-B-activating kinase (TBK1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | NF-kappa-B-activating kinase (TBK1) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.